NITETIME- acetaminophen, dextromethorphan hydrobromide, doxylamine succinate capsule, liquid filled
PuraCap Pharmaceutical LLC
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Acetaminophen 325 mg
Dextromethorphan HBr 15 mg
Doxylamine Succinate 6.25 mg
temporarily relieves common cold/flu symptoms:
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take:
Sore throat warning: If sore throat is severe, lasts more than 2 days, occurs with or is followed by fever, headache, rash, nausea, or vomiting, see a doctor promptly.
These could be signs of a serious condition.
Overdose warning: Taking more than directed can cause serious health problems. In case of overdose, get medical help or contact a Poison Control Center right away. Quick medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.
adults and children 12 years of age and over | swallow 2 softgels with water every 4 hours |
children 4 to under 12 years of age | ask a doctor |
children under 4 years of age | do not use |
D&C Yellow # 10, FD&C Blue #1, gelatin, glycerin, polyethylene glycol, povidone, propylene glycol, purified water, sorbitol special, and white edible ink
MULTI-SYMPTOM
NiteTime Liquid Capsules
NDC 51013-106-01
acetaminophen, dextromethorphan hydrobromide, doxylamine succinate
pain reliever, fever reducer, cough suppressant,antihistamine
fever, headache, sore throat, coughing, minor aches and pains, runny nose and sneezing
Compare to the active ingredients in Vicks® NyQuil®*
*This product is not manufactured or distributed by Procter & Gamble, owner of the registered trademark Vicks® NyQuil®
KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION
THIS PRODUCT IS PACKAGED IN A CHILD RESISTANT AND TAMPER EVIDENT PACKAGE. USE ONLY IF BLISTERS ARE INTACT.
NITETIME
acetaminophen, dextromethorphan hydrobromide, doxylamine succinate capsule, liquid filled |
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Labeler - PuraCap Pharmaceutical LLC (962106329) |
Registrant - Humanwell Puracap Pharmaceuticals (Wuhan) Co., Ltd (421293287) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Humanwell Puracap Pharmaceuticals (Wuhan) Co., Ltd | 421293287 | manufacture(51013-106) , analysis(51013-106) |